EUVIMEDEUVIMED entdecken
Crossref

Validity, reliability and responsiveness of digital visual analogue scales for chronic spontaneous urticaria monitoring: A CRUSE ® mobile health study

Bernardo Sousa-Pinto iD, Aiste Ramanauskaite iD, Sophia Neisinger iD, Ellen Witte-Händel iD, Ana M Gimenez-Arnau iD, Carole Guillet iD, Claudio Alberto S Parisi iD, Constance H Katelaris iD, Daria Fomina iD, Désirée Larenas-Linnemann iD, Elizabeth García iD, Emek Kocatürk iD und 42 weitere

Allergy · 2025-03 · 80 (3) · 750-761

DOI: 10.1111/all.16371 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Allergy, online erschienen am 24.10.2024. Verfasst von Bernardo Sousa-Pinto und 53 weiteren Autor:innen. Beteiligte Einrichtung: MEDCIDS-Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal. Hauptthemen laut MEDLINE: Chronic Urticaria, Visual Analog Scale, Mobile Applications. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

CRUSE® is an app that allows patients with chronic spontaneous urticaria (CSU) to monitor their daily disease activity through the use of visual analogue scales (VASs). We aimed to determine the concurrent validity, reliability, responsiveness and minimal important difference (MID) of CRUSE® VASs. Method s We evaluated the properties of three daily VASs: VAS for how much patients were affected by their CSU (‘VAS urticaria’), VAS for the impact of urticaria on work/school productivity (‘VAS productivity’) and the VAS of EQ‐5D. Concurrent validity was assessed by measuring the association between each VAS and the Urticaria Activity Score (UAS). Intra‐rater reliability was determined based on the data of users providing multiple daily questionnaires within the same day. Test–retest reliability and responsiveness (ability to change), respectively, were tested in clinically stable and clinically unstable users. MIDs were determined using distribution‐based methods.

Results

We included 5938 patients (67,380 days). Concurrent validity was high, with VAS urticaria being more strongly associated with the UAS score than the remaining VASs. Intra‐rater reliability was also high, with intraclass correlation coefficients (ICC) being above 0.950 for all VASs. Moderate‐high test–retest reliability and responsiveness were observed, with reliability ICC being highest for VAS EQ‐5D and responsiveness being highest for VAS urticaria. The MID for VAS urticaria was 17 (out of 100) units, compared to 15 units for VAS productivity and 11 units for VAS EQ‐5D.

Conclusion

Daily VASs for CSU available in the CRUSE® app display high concurrent validity and intra‐rater reliability and moderate‐high test–retest reliability and responsiveness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chronic UrticariaVisual Analog ScaleMobile ApplicationsHumansFemaleMaleReproducibility of ResultsAdultMiddle AgedSurveys and QuestionnairesSeverity of Illness IndexTelemedicineYoung AdultAged

Stichwörter der Autor:innen

mHealthpatient‐reported outcome measuresurticaria, chronic spontaneous urticaria

Autor:innen und Institutionen

  • MEDCIDS-Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal.
  • CINTESIS-Center for Health Technology and Services Research, University of Porto, Porto, Portugal.
  • RISE-Health Research Network, University of Porto, Porto, Portugal.
  • Institute of Allergology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany.
  • Department of Dermatology, Urticaria Center of Reference, and Excellence (UCARE), Hospital del Mar, IMIM, Universitat Pompeu Fabra, Barcelona, Spain.

ORCID-Profile: Bernardo Sousa-Pinto, Aiste Ramanauskaite, Sophia Neisinger, Ellen Witte-Händel, Ana M Gimenez-Arnau, Carole Guillet, Claudio Alberto S Parisi, Constance H Katelaris, Daria Fomina, Désirée Larenas-Linnemann, Elizabeth García, Emek Kocatürk, Frank Siebenhaar, Hermenio Lima, Igor Kaidashev, Iman Nasr, Isabel Ogueta Canales, Ivan Cherrez Ojeda, Jean Bousquet, Jonathan A Bernstein, Jonny Peter, Jorge Sanchez, Jose Ignacio Larco Sousa, Kanokvalai Kulthanan, Karsten Weller, Kiran Godse, Krzysztof Rutkowski, Lasma Lapina, Laurence Bouillet, Leo Lianyi Han, Luis Felipe Ensina, Margarida Gonçalo, Markus Magerl, Martijn van Doorn, Martin Metz, Maryam Khoshkhui, Michihiro Hide, Murat Türk, Nataļja Kurjāne, Niall Conlon, Pascale Salameh, Pavel Kolkhir, Riccardo Asero, Roman Stepanenko, Sabine Altrichter, Sara Gil-Mata, Simon Francis Thomsen, Torsten Zuberbier, Vladyslav Tsaryk, Young-Min Ye, Zenon Brzoza, Zuotao Zhao, Marcus Maurer

Zitieren

APA

Sousa-Pinto, B., Ramanauskaite, A., Neisinger, S., Witte-Händel, E., Gimenez-Arnau, A. M., Guillet, C., Parisi, C. A. S., Katelaris, C. H., Fomina, D., Larenas-Linnemann, D., García, E., Kocatürk, E., Siebenhaar, F., Lima, H., Kaidashev, I., Nasr, I., Canales, I. O., Ojeda, I. C., Hébert, J., …, & Maurer, M. (2025). Validity, reliability and responsiveness of digital visual analogue scales for chronic spontaneous urticaria monitoring: A CRUSE ® mobile health study. Allergy, 80(3), 750-761. https://doi.org/10.1111/all.16371

Vancouver

Sousa-Pinto B, Ramanauskaite A, Neisinger S, Witte-Händel E, Gimenez-Arnau AM, Guillet C, et al. Validity, reliability and responsiveness of digital visual analogue scales for chronic spontaneous urticaria monitoring: A CRUSE ® mobile health study. Allergy. 2025;80(3):750-761. doi:10.1111/all.16371

BibTeX
@article{SousaPinto2025,
  author = {Sousa-Pinto, Bernardo and Ramanauskaite, Aiste and Neisinger, Sophia and Witte-Händel, Ellen and Gimenez-Arnau, Ana M and Guillet, Carole and Parisi, Claudio Alberto S and Katelaris, Constance H and Fomina, Daria and Larenas-Linnemann, Désirée and García, Elizabeth and Kocatürk, Emek and Siebenhaar, Frank and Lima, Hermenio and Kaidashev, Igor and Nasr, Iman and Canales, Isabel Ogueta and Ojeda, Ivan Cherrez and Hébert, Jacques and Bousquet, Jean and Bernstein, Jonathan A and Peter, Jonny and Sanchez, Jorge and Sousa, Jose Ignacio Larco and Kulthanan, Kanokvalai and Weller, Karsten and Godse, Kiran and Rutkowski, Krzysztof and Lapina, Lasma and Bouillet, Laurence and Han, Leo Lianyi and Ensina, Luis Felipe and Gonçalo, Margarida and Magerl, Markus and van Doorn, Martijn and Metz, Martin and Khoshkhui, Maryam and Hide, Michihiro and Türk, Murat and Kurjāne, Nataļja and Conlon, Niall and Salameh, Pascale and Kolkhir, Pavel and Asero, Riccardo and Stepanenko, Roman and Altrichter, Sabine and Gil-Mata, Sara and Thomsen, Simon Francis and Zuberbier, Torsten and Tsaryk, Vladyslav and Ye, Young-Min and Brzoza, Zenon and Zhao, Zuotao and Maurer, Marcus},
  title = {Validity, reliability and responsiveness of digital visual analogue scales for chronic spontaneous urticaria monitoring: A CRUSE ® mobile health study},
  journal = {Allergy},
  year = {2025},
  volume = {80},
  number = {3},
  pages = {750--761},
  doi = {10.1111/all.16371}
}
Kostenlos starten →